Development and Validation of a Method for Quantitative Determination of Innovative Antitumor Peptide Drugs in Order to Study their Pharmacokinetics

Authors

  • Valery V. Smirnov I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8 Trubetskaya str., Mosсow, RU-119991, Russia
  • Elizaveta N. Fisher I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8 Trubetskaya str., Mosсow, RU-119991, Russia; LLC «CPHA», 20/3, Nauchnyproezd, Moscow, RU-117246, Russia
  • Galina V. Ramenskaya I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8 Trubetskaya str., Mosсow, RU-119991, Russia

DOI:

https://doi.org/10.33892/aph.2021.91.316-317

Keywords:

Oligopeptides, pharmacokinetics, HPLC-MS/MS, clinical and pharmacological studies, sample preparation

Published

2021-11-15

How to Cite

(1)
Smirnov, V. V.; Fisher, E. N.; Ramenskaya, G. V. Development and Validation of a Method for Quantitative Determination of Innovative Antitumor Peptide Drugs in Order to Study Their Pharmacokinetics. Acta Pharm Hung 2021, 91, 316-317.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License